vs
Side-by-side financial comparison of Electromed, Inc. (ELMD) and Spire Global, Inc. (SPIR). Click either name above to swap in a different company.
Electromed, Inc. is the larger business by last-quarter revenue ($18.9M vs $15.8M, roughly 1.2× Spire Global, Inc.). Electromed, Inc. runs the higher net margin — 14.6% vs -176.6%, a 191.2% gap on every dollar of revenue. On growth, Electromed, Inc. posted the faster year-over-year revenue change (16.3% vs -26.9%). Electromed, Inc. produced more free cash flow last quarter ($2.4M vs $-16.2M). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs -32.6%).
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
Spire Global, Inc. is a space-to-cloud data and analytics company that specializes in the tracking of global data sets powered by a large constellation of nanosatellites, such as the tracking of maritime, aviation and weather patterns.
ELMD vs SPIR — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.9M | $15.8M |
| Net Profit | $2.8M | $-28.0M |
| Gross Margin | 78.4% | 40.2% |
| Operating Margin | 19.2% | -164.1% |
| Net Margin | 14.6% | -176.6% |
| Revenue YoY | 16.3% | -26.9% |
| Net Profit YoY | 40.3% | 42.7% |
| EPS (diluted) | $0.32 | $-0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.9M | $15.8M | ||
| Q3 25 | $16.9M | $12.7M | ||
| Q2 25 | $17.4M | $19.2M | ||
| Q1 25 | $15.7M | $23.9M | ||
| Q4 24 | $16.3M | $21.7M | ||
| Q3 24 | $14.7M | $28.6M | ||
| Q2 24 | $14.8M | $25.4M | ||
| Q1 24 | $13.9M | $34.8M |
| Q4 25 | $2.8M | $-28.0M | ||
| Q3 25 | $2.1M | $-19.7M | ||
| Q2 25 | $2.2M | $119.6M | ||
| Q1 25 | $1.9M | $-20.7M | ||
| Q4 24 | $2.0M | $-48.8M | ||
| Q3 24 | $1.5M | $-12.5M | ||
| Q2 24 | $1.8M | $-16.6M | ||
| Q1 24 | $1.5M | $-25.5M |
| Q4 25 | 78.4% | 40.2% | ||
| Q3 25 | 78.1% | 36.6% | ||
| Q2 25 | 78.3% | 48.9% | ||
| Q1 25 | 78.0% | 36.8% | ||
| Q4 24 | 77.7% | 32.4% | ||
| Q3 24 | 78.3% | 44.5% | ||
| Q2 24 | 76.2% | 43.0% | ||
| Q1 24 | 74.8% | 26.5% |
| Q4 25 | 19.2% | -164.1% | ||
| Q3 25 | 15.8% | -166.1% | ||
| Q2 25 | 17.5% | -122.7% | ||
| Q1 25 | 13.6% | -106.5% | ||
| Q4 24 | 15.6% | -144.1% | ||
| Q3 24 | 13.2% | -48.0% | ||
| Q2 24 | 15.7% | -48.6% | ||
| Q1 24 | 13.3% | -34.4% |
| Q4 25 | 14.6% | -176.6% | ||
| Q3 25 | 12.6% | -155.3% | ||
| Q2 25 | 12.7% | 623.4% | ||
| Q1 25 | 12.1% | -86.5% | ||
| Q4 24 | 12.1% | -225.2% | ||
| Q3 24 | 10.0% | -43.7% | ||
| Q2 24 | 12.3% | -65.2% | ||
| Q1 24 | 10.8% | -73.3% |
| Q4 25 | $0.32 | $-0.85 | ||
| Q3 25 | $0.25 | $-0.61 | ||
| Q2 25 | $0.26 | $3.72 | ||
| Q1 25 | $0.21 | $-0.77 | ||
| Q4 24 | $0.22 | $-1.93 | ||
| Q3 24 | $0.16 | $-0.50 | ||
| Q2 24 | $0.20 | $-0.68 | ||
| Q1 24 | $0.17 | $-1.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.8M | $81.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $45.4M | $112.9M |
| Total Assets | $54.9M | $211.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.8M | $81.8M | ||
| Q3 25 | $14.1M | $96.8M | ||
| Q2 25 | $15.3M | $117.6M | ||
| Q1 25 | $15.2M | $35.9M | ||
| Q4 24 | $16.2M | $19.2M | ||
| Q3 24 | $13.9M | $36.6M | ||
| Q2 24 | $16.1M | $45.8M | ||
| Q1 24 | $11.7M | $63.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $103.7M | ||
| Q4 24 | — | $103.1M | ||
| Q3 24 | — | $4.9M | ||
| Q2 24 | — | $4.9M | ||
| Q1 24 | — | $123.1M |
| Q4 25 | $45.4M | $112.9M | ||
| Q3 25 | $44.7M | $133.1M | ||
| Q2 25 | $43.2M | $149.2M | ||
| Q1 25 | $43.9M | $3.7M | ||
| Q4 24 | $43.6M | $-11.7M | ||
| Q3 24 | $41.5M | $30.8M | ||
| Q2 24 | $44.5M | $40.3M | ||
| Q1 24 | $42.5M | $52.5M |
| Q4 25 | $54.9M | $211.0M | ||
| Q3 25 | $53.6M | $224.3M | ||
| Q2 25 | $53.8M | $239.5M | ||
| Q1 25 | $52.5M | $208.8M | ||
| Q4 24 | $52.3M | $193.6M | ||
| Q3 24 | $48.9M | $224.2M | ||
| Q2 24 | $52.2M | $230.8M | ||
| Q1 24 | $48.9M | $252.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 27.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 2.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $-4.3M |
| Free Cash FlowOCF − Capex | $2.4M | $-16.2M |
| FCF MarginFCF / Revenue | 12.7% | -102.1% |
| Capex IntensityCapex / Revenue | 3.4% | 75.1% |
| Cash ConversionOCF / Net Profit | 1.10× | — |
| TTM Free Cash FlowTrailing 4 quarters | $7.9M | $-92.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $-4.3M | ||
| Q3 25 | $169.0K | $-12.0M | ||
| Q2 25 | $3.9M | $-35.1M | ||
| Q1 25 | $2.1M | $-8.4M | ||
| Q4 24 | $3.2M | $-19.2M | ||
| Q3 24 | $2.3M | $14.0M | ||
| Q2 24 | $4.5M | $-4.4M | ||
| Q1 24 | $1.4M | $-8.8M |
| Q4 25 | $2.4M | $-16.2M | ||
| Q3 25 | $-83.0K | $-20.4M | ||
| Q2 25 | $3.7M | $-38.7M | ||
| Q1 25 | $1.9M | $-17.3M | ||
| Q4 24 | $2.9M | $-24.3M | ||
| Q3 24 | $2.3M | $5.1M | ||
| Q2 24 | $4.5M | $-9.9M | ||
| Q1 24 | $1.3M | $-15.9M |
| Q4 25 | 12.7% | -102.1% | ||
| Q3 25 | -0.5% | -161.3% | ||
| Q2 25 | 21.4% | -201.7% | ||
| Q1 25 | 12.2% | -72.6% | ||
| Q4 24 | 18.0% | -112.2% | ||
| Q3 24 | 15.5% | 17.8% | ||
| Q2 24 | 30.1% | -39.0% | ||
| Q1 24 | 9.1% | -45.7% |
| Q4 25 | 3.4% | 75.1% | ||
| Q3 25 | 1.5% | 66.2% | ||
| Q2 25 | 0.8% | 18.8% | ||
| Q1 25 | 1.0% | 37.3% | ||
| Q4 24 | 1.4% | 23.5% | ||
| Q3 24 | 0.3% | 31.2% | ||
| Q2 24 | 0.1% | 21.8% | ||
| Q1 24 | 0.6% | 20.3% |
| Q4 25 | 1.10× | — | ||
| Q3 25 | 0.08× | — | ||
| Q2 25 | 1.75× | -0.29× | ||
| Q1 25 | 1.10× | — | ||
| Q4 24 | 1.60× | — | ||
| Q3 24 | 1.57× | — | ||
| Q2 24 | 2.46× | — | ||
| Q1 24 | 0.90× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
SPIR
Segment breakdown not available.
